ARROWHEAD PHARMACEUTICALS, INC.

By person

23 insiders · 428 transactions

337×

Christopher Anzalone holds 337 times base salary in stock. $331.11M of shares against $981.05K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Anzalone last reported holding, valued at $87.30, the price Common Stock was last bought or sold at on the open market here, on 18 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Anzalone Christopher Richard

Chief Executive Officer

—

$108.95M (106)

−$108.95M

3,792,739

$331.11M

+223.4%

Myszkowski Kenneth Allen

Chief Financial Officer

—

$23.21M (43)

−$23.21M

455,433

$39.76M

+19,305%

O'Brien Patrick

COO

—

$20.67M (50) scheduled

−$20.67M

547,408

$47.79M

+1,725%

Hamilton James C

Chief Medical Officer

—

$14.39M (56) scheduled

−$14.39M

226,958

$19.81M

+91.1%

GIVEN BRUCE D

Chief Operating Officer

—

$14.16M (34) scheduled

−$14.16M

850,730

$74.27M

+116.3%

PERRY MICHAEL S

Director

—

$9.33M (10)

−$9.33M

201,459

$17.59M

+22.1%

GIVEN DOUGLAS B

Director

$43.47K (1)

$5.26M (21)

−$5.21M

137,167

$11.97M

+103.8%

San Martin Javier

Chief Medical Officer

—

$4.15M (11)

−$4.15M

198,497

$17.33M

+32.3%

Waddill William D.

Director

—

$2.84M (16)

−$2.84M

56,563

$4.94M

+1,885,333%

Ferrari Mauro

Director

—

$2.34M (7)

−$2.34M

69,053

$6.03M

—

Bradshaw Curt

Chief Scientific Officer

—

$2.16M (2)

−$2.16M

$0.00

−100.0%

OLUKOTUN ADEOYE Y

Director

—

$1.88M (12)

−$1.88M

31,600

$2.76M

+531.6%

Leone Peter Brian

VP, Strategic Bus. Initiatives

—

$1.77M (1) scheduled

−$1.77M

130,000

$11.35M

—

Hassard James

Chief Commercial Officer

—

$1.50M (2)

−$1.50M

105,750

$9.23M

−15.4%

Vakiener Victoria

Director

—

$1.14M (8) scheduled

−$1.14M

35,723

$3.12M

+107.9%

Apel Daniel Joseph

Chief Financial Officer

—

$934.29K (3) scheduled

−$934.29K

162,905

$14.22M

+61.3%

Li Zhen

Snr. VP, Chem and Non-Clin Dev

—

$580.77K (1)

−$580.77K

201,700

$17.61M

+20.6%

De Backer Marianne

Director

$184.71K (10)

$740.43K (4)

−$555.72K

31,267

$2.73M

+525.3%

Oliver Tracie

Chief Commercial Officer

—

$555.13K (3)

−$555.13K

127,107

$11.10M

+81.6%

Lu Hongbo

Director

$82.99K (3)

$228.33K (1) scheduled

−$145.34K

52,012

$4.54M

+89.6%

FRYKMAN EDWARD W

Director

—

148,852

$12.99M

+101.6%

INGRAM DOUGLAS S

Director

—

46,215

$4.03M

—

Cohen Matthew Gregory

Director

—

11,882

$1.04M

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

ARROWHEAD PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out